Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tildipirosin is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Tildipirosin Tildipirosin Bovine, caprine 400 μg/kg Muscle Not for use in animals from which milk is produced for human consumption. Anti-infectious agents/Antibiotics’
200 μg/kg Fat
2 000 μg/kg Liver
3 000 μg/kg Kidney
Porcine 1 200 μg/kg Muscle
800 μg/kg Skin and fat in natural proportions
5 000 μg/kg Liver
10 000 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Tildipirosin	Tildipirosin	Bovine, caprine	400 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption.	Anti-infectious agents/Antibiotics’
			200 μg/kg	Fat
			2 000 μg/kg	Liver
			3 000 μg/kg	Kidney
		Porcine	1 200 μg/kg	Muscle
			800 μg/kg	Skin and fat in natural proportions
			5 000 μg/kg	Liver
			10 000 μg/kg	Kidney